IFP Advisors, Inc BBIO — BRIDGEBIO PHARMA INC COM

Ownership history in IFP Advisors, Inc  ·  10 quarters on record

AI Ownership Summary

IFP Advisors, Inc reported BRIDGEBIO PHARMA INC COM (BBIO) in 10 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows BBIO at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this BBIO ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was IFP Advisors, Inc's position in BRIDGEBIO PHARMA INC COM, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

BBIO was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

BBIO stock page IFP Advisors, Inc fund profile IFP Advisors, Inc full holdings
How IFP Advisors, Inc held BBIO — position size vs. price
% of Fund (quarterly)    BBIO price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 801 +517 +182.0% 0.00% $59K 2026-04-13 $77.87
2025 Q4 REDUCED 17.0% -2.9% ✅ 284 -58 -17.0% 0.00% $22K 2026-02-06 $68.05
2025 Q3 ADDED — — — 342 +298 +677.3% 0.00% $18K 2025-12-02 $71.46
2025 Q2 ADDED — — — 44 +30 +214.3% 0.00% $2K 2025-07-24 $45.66
2025 Q1 REDUCED 99.0% +24.9% ❌ 14 -1,432 -99.0% 0.00% $484 2025-05-05 $38.22
2024 Q4 REDUCED 38.5% +26.0% ❌ 1,446 -905 -38.5% 0.00% $37K 2025-02-04 $32.98
2024 Q2 ADDED — — — 2,351 +1,801 +327.5% 0.00% $73K 2024-07-30 $25.94
2023 Q4 REDUCED 45.0% -25.7% ✅ 550 -450 -45.0% 0.00% $22K 2024-01-09 $39.73
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding BBIO

As of 2026 Q1 — sorted by position size

MOODY ALDRICH PARTNERS LLC 3Y 7Y 1.02% TEMA ETFS LLC 0.56% DIAMANT ASSET MANAGEMENT, INC. 3Y 7Y 0.38% PSP Research LLC 0.32% Total Clarity Wealth Management, Inc. 3Y 0.24% Yorktown Management & Research Co Inc 3Y 7Y 0.2% Bayforest Capital Ltd 0.16% Pictet Asset Management Holding SA 0.11% First Bank & Trust 3Y 7Y 0.1% Central Pacific Bank - Trust Division 0.07%

FAQ About IFP Advisors, Inc and BBIO

These are the practical questions this page is built to answer before you even open the full history table.

How long has IFP Advisors, Inc reported owning BBIO?

IFP Advisors, Inc reported BBIO across 8 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported BBIO position in IFP Advisors, Inc's portfolio?

The largest reported portfolio weight for BBIO was 0.00% in 2024 Q2.

What is the latest reported BBIO position on this page?

The most recent filing on this page is 2026 Q1, when IFP Advisors, Inc reported 801 shares, equal to 0.00% of portfolio, with an estimated market value of $59K.

What does the chart on this BBIO ownership page compare?

The chart compares IFP Advisors, Inc's quarterly BBIO portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did IFP Advisors, Inc time their BBIO position?

Based on 13F filing dates vs. subsequent BBIO price moves, IFP Advisors, Inc correctly timed 4 out of 9 reported position changes (44%). The annualised alpha on BBIO relative to SPY over the holding period was +76.4%.

← Back to IFP Advisors, Inc Holdings